Volume 34 Number 6 February 12-19, 2015
Reviews, News and Commentaries
Fresh from the biotech pipeline—2014
Chris Morrison Nature Biotechnology 2015; 33:125-128
Chris Morrison Nature Biotechnology 2015; 33:125-128
Work that matters: Toward consequential environmental epidemiology
Frumkin, Howard, Epidemiology, March, 2015
Frumkin, Howard, Epidemiology, March, 2015
Patients and genomics: dual drivers of health system change? PHG Foundation, Feb 11
Head and neck cancer: Building the evidence base for precision oncology, by Dr. Francis Collins, NIH Director’s Blog, Feb 10
Policy statement on preconception carrier screening, PHG Foundation, Feb 10
The genome war, round two, by Reid J. Robison, Precision Medicine, Feb 10
A never-ending genetic quest. Mary-Claire King’s pioneering gene work, from breast cancer to human rights, New York Times, Feb 9
Why precision medicine will not create a medical revolution, by Michael White, Pacific Standard, Feb 9
Articles of the week: human genetics to assess on-target adverse drug events, by Robert Plenge, Plenege Gen Blog, Feb 7
Medicine just for you, by the Editorial Board, New York Times, Feb 7
Genetic screening deemed cost-effective in non–small cell lung cancer, The ASCO Post, Feb 6
Will the President's plan move precision medicine beyond the hype? By Turna Ray, Genome Web, Feb 6 [by free subscription only]
Doctor, have you had your DNA tested? By Robert Klitzman, M.D. , New York Times, Feb 5
Launch of new genomics initiative draws enthusiastic industry, academic partners, UC Berkeley News Center, Feb 5
Populations, individuals and imprecise disease prediction, by Ann Buchanan, Mermaid Tale Blog, Feb 5
The problem with precision medicine, by Cynthia Graber , New Yorker, Feb 5
Exploring genomic causal 'precision', by Ken Weiss , Mermaid Tale Blog, Feb 4
No hay comentarios:
Publicar un comentario